Healthy Skepticism Library item: 13531
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Whalen J.
Glaxo Becomes Master of Reinventing Drugs
The Wall Street Journal 2008 Apr 17
http://online.wsj.com/article/SB120833908419819167-email.html
Abstract:
London — GlaxoSmithKline PLC’s vast research labs haven’t been able to deliver many major innovations to the market in recent years, but they have become experts at another science: reinventing old drugs.
The approach has helped buttress the world’s second-largest drug company during one of the industry’s most difficult times. Glaxo says that modifying old drugs and finding new uses for them accounted for 27% of the company’s sales growth over the last seven years.
The Brentford, England-based drug giant usually rolls out the modified drugs just as the originals lose patent protection and face generic competition. On Wednesday, for …
